Member News
-
Fission 3 Welcomes New Director Nicky Grant
August 3, 2022 (Source) – Fission 3.0 Corp. (TSXV: FUU) (“Fission 3” or the “Company”) is pleased to announce the appointment…
-
Nano One Announces Results of Annual General Meeting
August 2, 2022 (Source) – Nano One ® Materials Corp. (TSX:NANO)(OTC PINK:NNOMF)(Frankfurt:LBMB) (the “Company”), a clean technology company with patented processes for the…
-
SIXW: Correction of News Release
August 2, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the…
-
Ur-Energy Releases 2022 Q2 Results
August 2, 2022 (Source) – Ur-Energy Inc. (NYSE American:URG) (TSX:URE) (the “Company” or “Ur-Energy”) has filed the Company’s Form 10-Q…
-
Alphamin Announces Updated Mineral Resource and Mineral Reserve Estimates and Life of Mine Schedule for Mpama North Tin Mine
August 2, 2022 (Source) – Alphamin Resources Corp. (AFM:TSXV, APH:JSE AltX, “Alphamin” or the “Company”), a producer of 4%…
-
Valeo Pharma Closes US$40 Million Non-Dilutive Financing from Sagard Healthcare Partners
Proceeds to fund acquisition of Canadian rights to 3 growing commercial stage drugs Acquisition allows Valeo to expand…
-
Valeo Pharma Enters into License Agreement with Kaléo for the Canadian Rights to ALLERJECT®
700,000 Canadians suffering from severe allergies Canadian epinephrine auto-injector market exceeds $80M annually ALLERJECT peak sales potential expected to…
-
Valeo Pharma Enters into an Agreement for Ophthalmic Products, PrXIIDRA® AND PrSIMBRINZA®, in Canada
Ophthalmology becomes additional strategic therapeutic area Significant market opportunities with more than 6 million1 Canadians suffering from dry eye…
-
Fission 3.0 Hits Alteration, Faulting at Murphy Lake
August 2, 2022 (Source) – Fission 3.0 Corp. (TSXV: FUU) (OTCQB: FISOF) (“Fission 3” or “the Company”) is pleased to…
-
Retirement of Mr Denis Geldard
20220801-Denis-Geldard-resignation-241400974.pdf
